Events

Videos

Podcasts

Articles

Gynecologic Oncology

The OncLive Gynecologic Oncology condition center page is a comprehensive resource for clinical news and expert insights on various types of gynecologic cancers, including ovarian cancer, endometrial cancer, and uterine cancer, among others. This section features news articles, interviews with gynecologic oncologists in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in gynecologic cancers.

As one of the most significant predictors of hereditary breast and ovarian cancer, the BRCA1/2 genes have become the poster child for genetic testing, thrust into the limelight by a high-profile court battle and a celebrity's disclosure.

The New BRCA1/2 Landscape

Latest News & Insight: November 26, 2014

PARP inhibitors represent an exciting new class of anticancer agents and are currently being evaluating in phase III for a number of different indications.

PARP Inhibitors for Breast and Ovarian Cancers

Challenges for the Future of Gynecologic Cancers

Emerging Therapies in Cervical Cancer

Bevacizumab in Recurrent Metastatic Cervical Cancer

Cervical Cancer Screening and Prevention

Promising Treatments in Ovarian Cancer 

Bevacizumab in Ovarian Cancer

Platinum Resistance in Ovarian Cancer

CA-125 Testing in Ovarian Cancer

Intraperitoneal Chemotherapy in Ovarian Cancer

Antiangiogenic Agents in Ovarian Cancer

Treatment Options in Ovarian Cancer

Chemotherapy Regimens for Ovarian Cancer

Goal of Surgery in Ovarian Cancer

Cytoreductive Surgery for Ovarian Cancer

Neoadjuvant Chemotherapy for Ovarian Cancer

Timing of Oophorectomy in Ovarian Cancer

Prophylactic Oophorectomy for Reducing Ovarian Cancer Risk

The OncLive Ovarian Cancer condition center page is a comprehensive resource for clinical news and expert insights on ovarian cancer and evolving treatment approaches, including PARP inhibitors, antibody-drug conjugates, chemotherapy and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in ovarian cancer.

Ovarian Cancer

GSK-22-OSD1278 - /clinical/ovarian-cancer

Ovarian Cancer | Specialty